欢迎来到天天文库
浏览记录
ID:208183
大小:121.50 KB
页数:4页
时间:2017-07-03
《SCD-HeFT研究PPT课件.ppt》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库。
1、SuddenCardiacDeathinHeartFailureTrialPresentedatAmericanCollegeofCardiologyScientificSessions2004PresentedbyDr.GustH.BardySCD-HeFTEndpoints(median45.5months):All-causemortalitySCD-HeFTPresentedatACCScientificSessions20042,521patientswithmoderatelysymp
2、tomaticCHF(NYHAClassIIorIII)andLVEF≤35%Randomized,double-blind,multicenterConventionalCHFTreatment+PlaceboConventionalCHFTreatment+ICDSingleleadimplantablecardioverterdefibrillatorprogrammedforventricularfibrillation(VF)treatmentonlyTreatmentConvention
3、alCHFTreatment+AmiodaroneAntiarrhythmicagent800mgWeek1,400mgWeek2-4Chronictherapy:200mg/dayif<150lbs300mg/dayif150-200lbs400mg/dayif>200lbsAll-causemortalityat5yearsAmiodaronevsplaceboHR1.06,p=0.529ICDvsplaceboHR0.77,p=0.007Medicationuseatendoffollow-u
4、pincluded72%ACE-inhibitors,78%beta-blockers,80%loopdiuretics,and55%ASAPriordurationofCHFwas24.5monthsatbaselineNodifferenceinall-causemortalitybetweenamiodaroneandplaceboarmMortalitywaslowerinICDarmvsplaceboPresentedatACCScientificSessions2004%Mortalit
5、ySCD-HeFTAmongpatientswithNYHAClassIIorClassIIICHFandreducedleftventricularejectionfraction,treatmentwithanimplantableICDwasassociatedwithareductioninall-causemortalitycomparedwithplacebo,buttherewasnodifferencebetweenamiodaroneandplaceboSecondaryendpo
6、intdatanotyetreportedSCD-HeFT
此文档下载收益归作者所有